ExxonMobil has expanded its portfolio of healthcare solutions to meet changing medical market needs for healthy, safe material options.

Adhering to industry requirements for testing, quality assurance and traceability, the portfolio unites a wide range of high-performance products that are produced using Good Manufacturing Practices (GMP) for batch-to-batch product consistency that customers can rely on.

The portfolio provides the building blocks to engineer a range of applications including medical supplies, infection protection products, and pharmaceutical and laboratory supplies.

The portfolio includes Achieve Advanced PP, ExxonMobil PP, Vistamaxx performance polymers, Exact polyolefin elastomers, ExxonMobil butyl polymers, Exxpro specialty elastomers and ExxonMobil Isopropyl Alcohol (IPA).

The COVID-19 pandemic, which required rapid production of face masks and other products to help combat virus transmission, was a major factor in the company’s decision to create a portfolio of healthcare solutions.

ExxonMobil expands its portfolio of healthcare solutions.

The healthcare industry’s desire for a polyvinyl chloride (PVC) replacement was another market driver which led ExxonMobil to develop suitable alternatives. While another motivating factor was customers’ preference to do business with a single-source materials supplier.

ExxonMobil’s high-quality, compliant-safe material solutions enable tailored innovation for:

• Optimized performance and longevity of medical supplies, including drug/medical fluid delivery. Applications include syringes, infusion bags, IV/saline containers, ostomy bags, inhaling systems, drug and vitamin tubes, bottles, vials, containers, caps, seals, closures, briefs, and absorbent pads.

• Purity required to meet the toughest standards for laboratory components and pharmaceutical packaging solutions, including labware, sanitizers, bio reactor bags, and pharmaceutical stoppers/seals.

• Cleanliness and safety for protective products, such as face masks, gowns, gloves and alcohol wipes that help prevent infection.

• Softness, loft, strength, improved barrier performance and ease of processing for spunbond or meltblown nonwoven products. Typical applications include absorbent articles, medical PPE, bandages, masks, gowns and wipes, surgical drapes and gowns, medical protective gowns, shoe covers, disposable bedding and hospital apparel, pads, wraps, and filtration media.

“It really is the sum of the parts that makes our healthcare portfolio so attractive to customers,” said Abigail Agentis, Americas Market Development Manager at ExxonMobil. “We seek to meet industry needs with a trusted portfolio of performance products that adhere to strict industry requirements for testing, quality assurance and traceability.”

To support its commitment to the healthcare industry, the company is dedicated to fulfilling the future business needs of its customers by continuing to invest in production capacity and comprehensive supply chains.

For example, its Polypropylene Growth Project in Baton Rouge is nearing completion, and the company continues to make good progress in support of a 2023 startup of the US$2 billion investment to expand its Baytown chemical plant with a new Vistamaxx unit and world-scale, full range Linear Alpha Olefins unit.

ExxonMobil has expanded its portfolio of healthcare solutions to meet changing medical market needs for healthy, safe material options.

Adhering to industry requirements for testing, quality assurance and traceability, the portfolio unites a wide range of high-performance products that are produced using Good Manufacturing Practices (GMP) for batch-to-batch product consistency that customers can rely on.

The portfolio provides the building blocks to engineer a range of applications including medical supplies, infection protection products, and pharmaceutical and laboratory supplies.

The portfolio includes Achieve Advanced PP, ExxonMobil PP, Vistamaxx performance polymers, Exact polyolefin elastomers, ExxonMobil butyl polymers, Exxpro specialty elastomers and ExxonMobil Isopropyl Alcohol (IPA).

The COVID-19 pandemic, which required rapid production of face masks and other products to help combat virus transmission, was a major factor in the company’s decision to create a portfolio of healthcare solutions.

ExxonMobil expands its portfolio of healthcare solutions.

The healthcare industry’s desire for a polyvinyl chloride (PVC) replacement was another market driver which led ExxonMobil to develop suitable alternatives. While another motivating factor was customers’ preference to do business with a single-source materials supplier.

ExxonMobil’s high-quality, compliant-safe material solutions enable tailored innovation for:

• Optimized performance and longevity of medical supplies, including drug/medical fluid delivery. Applications include syringes, infusion bags, IV/saline containers, ostomy bags, inhaling systems, drug and vitamin tubes, bottles, vials, containers, caps, seals, closures, briefs, and absorbent pads.

• Purity required to meet the toughest standards for laboratory components and pharmaceutical packaging solutions, including labware, sanitizers, bio reactor bags, and pharmaceutical stoppers/seals.

• Cleanliness and safety for protective products, such as face masks, gowns, gloves and alcohol wipes that help prevent infection.

• Softness, loft, strength, improved barrier performance and ease of processing for spunbond or meltblown nonwoven products. Typical applications include absorbent articles, medical PPE, bandages, masks, gowns and wipes, surgical drapes and gowns, medical protective gowns, shoe covers, disposable bedding and hospital apparel, pads, wraps, and filtration media.

“It really is the sum of the parts that makes our healthcare portfolio so attractive to customers,” said Abigail Agentis, Americas Market Development Manager at ExxonMobil. “We seek to meet industry needs with a trusted portfolio of performance products that adhere to strict industry requirements for testing, quality assurance and traceability.”

To support its commitment to the healthcare industry, the company is dedicated to fulfilling the future business needs of its customers by continuing to invest in production capacity and comprehensive supply chains.

For example, its Polypropylene Growth Project in Baton Rouge is nearing completion, and the company continues to make good progress in support of a 2023 startup of the US$2 billion investment to expand its Baytown chemical plant with a new Vistamaxx unit and world-scale, full range Linear Alpha Olefins unit.